Medical News

RSS

International development forum addresses U.S. foreign aid reform

USAID Administrator Rajiv Shah and Rep. Gerald Connolly (D-Va.) discussed the need for a new foreign aid strategy and vision at an international development forum, hosted by InterAction on Wednesday, Congressional Quarterly reports.

4 Jun 2010

Study: Delays in seeking health care appear to be common for Latino women

Delays in seeking health care appear to be common for Latino women in upstate New York, a new study finds. In the latest issue of the journal Ethnicity & Disease, about 70 percent of a group of mostly Caribbean Latinas in the Albany area reported they put off getting health care. Insurance did not seem to be an issue, since 80 percent had insurance, yet 60 percent of the women said that they had a prior chronic medical condition.

4 Jun 2010

Nutrient found in maternal diet provide lasting cognitive, emotional benefits to people with Down syndrome: Study

A nutrient found in egg yolks, liver and cauliflower taken by mothers during pregnancy and nursing may offer lifelong "dramatic" health benefits to people with Down syndrome.

4 Jun 2010

European countries focus on drug price cuts

"European governments grappling to reduce large budget deficits are focusing their cost-cutting on a large spending item — pharmaceuticals," The Wall Street Journal reports. "Several countries in recent weeks, including Spain, Germany and Italy, have proposed or enacted reductions in what they will pay or taken other cost-control measures for various drugs.

4 Jun 2010

FDA approves Perrigo's ANDA for OTC Miconazole Nitrate Vaginal Cream and Suppository

Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Miconazole Nitrate Vaginal Cream and Suppository, a generic to Monistat® -1 Combination Pack. Perrigo expects to begin shipping immediately.

4 Jun 2010

Mass. insurers ask for double-digit rate hikes, again

Massachusetts' two largest insurers have again asked regulators for permission to increase their rates. "Blue Cross Blue Shield of Massachusetts, the state's biggest health insurer, is requesting increases averaging 12 percent, on the lower end of the range it submitted earlier in the spring. Harvard Pilgrim Health Care, the number two carrier, wants increases that range from 8.8 percent to 11.9 percent, about the same range it sought in the round that was rejected" (Weisman, 6/3).

4 Jun 2010

New pricing of $19,500 set for Illumina's individual genome sequencing service

Illumina, Inc. today announced a new price of $19,500 for its individual genome sequencing service. In addition, the company announced a price of $14,500 per genome for groups of five or more participants using the same physician. Individuals with serious medical conditions for whom whole-genome sequencing could provide potential direct clinical value will be eligible for special pricing of $9,500 per genome.

From Illumina, Inc. 4 Jun 2010

GHP selects MirixaPro web-based clinical platform to support delivery of MTM services

The Geisinger Health Plan, a regional provider of health benefits to almost 250,000 members in Pennsylvania, has selected Mirixa Corporation's MirixaPro web-based clinical platform to support the delivery of medication therapy management services to its Medicare Part D members.

4 Jun 2010

Health overhaul politics churn as regulators move forward

Los Angeles Times: "Congress is shattering its longstanding reputation for being a gridlocked, lethargic, 'do-nothing' institution, instead compiling a record of landmark policy changes in healthcare, financial industry regulation, economic policy and more. But at the same time, Congress is suffering sky-high levels of public disapproval, signaling a big problem for Democrats as they head into the closing months of the midterm election campaign" (Hook, 6/2).

4 Jun 2010

Drug makers push for more time to pay half-off discount on drugs

Drug makers want 60 days instead of 15 to pay a half-off discount for branded drugs in a Medicare Part D coverage gap, Inside Health Policy reports. The Centers for Medicare and Medicaid Services also intends to ask drug makers to pay disputed amounts ahead of a decision about whether the company must pay the discount.

4 Jun 2010

Anulex Technologies completes $20M Series E financing round

Anulex Technologies, Inc., a privately held medical device manufacturer focusing on soft tissue Preservation & Anular Repair products, announced the first closing of its fifth round of private equity financing which will total a minimum of $20 million. The Series E round was led by a new unnamed strategic investor with participation from existing investors Affinity Capital, Delphi Ventures, MB Venture Partners, New Enterprise Associates, SightLine Partners and Split Rock Partners.

4 Jun 2010

Antiviral drug oseltamivir appears safe and effective for infants hospitalized with influenza: Study

Given promptly, the antiviral drug oseltamivir (Tamiflu) appears safe and effective for infants hospitalized with influenza, reports a study in the June issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

4 Jun 2010

Early detection and removal of pancreatic cysts may lower cancer risk: Researchers

Working with researchers from the University of Michigan and Indiana University, Van Andel Research Institute investigators have developed a method that could be used to predict whether pancreatic cysts are benign or are precursors to invasive cancer.

4 Jun 2010

Today's OpEds: New Republic and National Review on health law; Conservative bloggers blast CBO numbers

The shouting war over health reform's effect on the budget got a little louder today when the director of the Office of Management and Budget, Peter Orszag, pushed back at conservative bloggers who are saying federal officials were disingenuous about the real costs of the law (Kate Steadman, 6/2).

4 Jun 2010

Abortion opponents focus on state law

"At least 11 states have passed laws this year regulating or restricting abortion, giving opponents of abortion what partisans on both sides of the issue say is an unusually high number of victories," The New York Times reports.

4 Jun 2010

Writer advocates for community inclusion for children and families living with autism

Lisa Jo Rudy is a writer, a social media guru, and above all a parent of a child with an autism spectrum disorder. She knows first hand what it takes to get out, have fun and explore the world with autistic children. In her groundbreaking new book, "Get Out, Explore, and Have Fun: How Families of Children with Autism or Asperger Syndrome Can Get the Most Out of Community Activities," Lisa Jo Rudy explores options, offers tips and guides parents in their steps to get their children involved in life outside of home, school, and therapists' offices.

4 Jun 2010

FDA clears Abbott's new ARCHITECT HE4 assay for monitoring ovarian cancer

The U.S. Food and Drug Administration (FDA) has cleared a new diagnostic test to monitor ovarian cancer, a disease that will strike an estimated one out of every 71 women in the United States in their lifetimes. Abbott's new ARCHITECT HE4 (human epididymis protein 4) assay, the first automated test of its kind available in the United States, uses a simple blood test to aid in monitoring for the recurrence or progression of this disease.

4 Jun 2010

AMA launches ad campaign to push Senators on 'doc fix'

CNN Money: The American Medical Association is launching an ad campaign to push lawmakers to stop a scheduled 21 percent cut to Medicare doctors' pay. "The House voted May 28 to delay the cuts for 19 months, but the Senate did not take action before the Memorial Day recess. The AMA's TV, radio and print ads slam senators for failing to pass the 'doc fix' before taking their week-long break.

4 Jun 2010

Tioga commences dosing in Phase 3 trial of asimadoline for diarrhea-predominant irritable bowel syndrome

Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.

4 Jun 2010

Legionnaires' disease kills a 66 year old

There has been a death with Legionnaire’s disease in Doncaster. This disease is caused by bacteria that infects people when they breathe in infested water droplets, such as spray drifts from cooling towers.

3 Jun 2010

Medical News

International development forum addresses U.S. foreign aid reform

Study: Delays in seeking health care appear to be common for Latino women

Nutrient found in maternal diet provide lasting cognitive, emotional benefits to people with Down syndrome: Study

European countries focus on drug price cuts

FDA approves Perrigo's ANDA for OTC Miconazole Nitrate Vaginal Cream and Suppository

Mass. insurers ask for double-digit rate hikes, again

New pricing of $19,500 set for Illumina's individual genome sequencing service

GHP selects MirixaPro web-based clinical platform to support delivery of MTM services

Health overhaul politics churn as regulators move forward

Drug makers push for more time to pay half-off discount on drugs

Anulex Technologies completes $20M Series E financing round

Antiviral drug oseltamivir appears safe and effective for infants hospitalized with influenza: Study

Early detection and removal of pancreatic cysts may lower cancer risk: Researchers

Today's OpEds: New Republic and National Review on health law; Conservative bloggers blast CBO numbers

Abortion opponents focus on state law

Writer advocates for community inclusion for children and families living with autism

FDA clears Abbott's new ARCHITECT HE4 assay for monitoring ovarian cancer

AMA launches ad campaign to push Senators on 'doc fix'

Tioga commences dosing in Phase 3 trial of asimadoline for diarrhea-predominant irritable bowel syndrome

Legionnaires' disease kills a 66 year old

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News